Company intelligence / Profile preview

Aton Pharma

Lawrenceville, New Jersey, United Statesatonbio.com ↗

Ownership: Private
Development stage: Other

Overview

Aton Pharma was a specialty pharmaceutical and biotechnology company focused on developing drugs primarily in oncology and neurology. Its most notable product was carbidopa for Parkinson’s disease. The company also developed small molecules targeting HDACs and DDC enzymes with some programs reaching approval while others were discontinued or pending. It held patents related to ocular drug delivery devices. The company had global sales in over thirty countries before being acquired from Merck & Co.

Therapeutic areas: OtherOphthalmologyOncologyNeurology
Modalities: Small moleculeDrug delivery device
Industry: Biotech

Partnerships

No major partnerships listed beyond parent/investors

Beyond the preview

Go deeper on Aton Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aton Pharma.

Explore the full profile